US Broker Ratings

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A 29% Upside Potential with Robust Revenue Growth

Alignment Healthcare, Inc. (NASDAQ: ALHC) is capturing investor attention with its robust growth in revenue and a potential upside of nearly 30%, according to analyst estimates. The company, based in..

Concentra Group Holdings (CON) Stock Analysis: Potential for 30% Upside in Healthcare Sector

Concentra Group Holdings Parent, Inc. (CON), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is catching the attention of investors with a compelling potential..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Biotechnology Innovator with a 45% Upside Potential

For investors seeking exposure in the biotechnology sector, MoonLake Immunotherapeutics (NASDAQ: MLTX) offers a compelling opportunity. With a focus on innovative treatments for inflammatory skin and joint diseases, this Swiss-based..

Warby Parker Inc. (WRBY) Stock Analysis: Exploring a 12.97% Upside Potential

Warby Parker Inc. (NYSE: WRBY), a prominent player in the eyewear industry, is drawing attention from investors with its potential upside of 12.97%. Renowned for transforming the optical market with..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Unveiling a 214% Potential Upside

In the dynamic world of biotechnology, Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) presents a compelling case for investors with a significant upside potential. Known for its innovative approach to treating rare..

Amedisys Inc (AMED): Analyst Consensus and Growth Potential in the Healthcare Sector

Amedisys Inc. (NASDAQ: AMED) stands as a notable player in the healthcare industry, particularly within the medical care facilities segment. With a market capitalization of $3.32 billion, Amedisys is well-positioned..

DENTSPLY SIRONA Inc. (XRAY): Investor Outlook with a 35% Potential Upside

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) is a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $2.5 billion, DENTSPLY SIRONA..

SpringWorks Therapeutics, Inc. (SWTX) Stock Analysis: High Revenue Growth Amidst Strategic Biotech Innovations

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) stands as a promising figure in the biotechnology sector, driven by its focus on developing therapies for rare diseases and cancers. With a market capitalization..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Growth Potential and Analyst Consensus Signal a Promising Future

iRhythm Technologies, Inc. (NASDAQ: IRTC), a prominent player in the healthcare sector, specifically within the medical devices industry, is attracting attention from investors for its innovative approach to cardiac monitoring...

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Unlocking a 23.58% Upside Potential with Solid Analyst Confidence

Bio-Rad Laboratories, Inc. (NYSE: BIO), a key player in the healthcare sector, is renowned for its advanced medical devices and diagnostics. With a market capitalization of $7.12 billion, the company..

Vaxcyte, Inc. (PCVX) Stock Analysis: A 284% Potential Upside Awaits Investors

Vaxcyte, Inc. (NASDAQ: PCVX), a biotechnology company dedicated to revolutionizing vaccine development, is capturing investor attention with its impressive potential upside of 284.20%. As the company advances its innovative pipeline,..

Madrigal Pharmaceuticals, Inc. (MDGL): Investor Outlook Reveals 26.81% Potential Upside

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is capturing attention in the biotechnology sector with its promising focus on developing treatments for metabolic dysfunction-associated steatohepatitis (MASH). Headquartered in West Conshohocken, Pennsylvania, Madrigal..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Unpacking the 48.20% Potential Upside in Genetic Medicine Innovations

Krystal Biotech, Inc. (NASDAQ: KRYS) is making waves in the biotechnology sector, standing out for its innovative approach to genetic medicines. With a market cap of $4.01 billion, this Pittsburgh-based..

TransMedics Group, Inc. (TMDX) Stock Analysis: Potential 24% Upside Amid Strong Revenue Growth

TransMedics Group, Inc. (NASDAQ: TMDX) is a pioneering force in the healthcare sector, specifically within the medical devices industry, with a focus on revolutionizing organ transplant therapy. Headquartered in Andover,..

Blueprint Medicines Corporation (BPMC) Stock Analysis: Navigating Growth in the Biotech Sector

Blueprint Medicines Corporation (NASDAQ: BPMC), a leading player in the biotechnology sector, continues to capture investor attention with its innovative approaches to treating genomically defined cancers and blood disorders. Headquartered..

Legend Biotech Corporation (LEGN) Stock Analysis: A Promising Biotech with a Potential Upside of 106%

Legend Biotech Corporation (NASDAQ: LEGN), a burgeoning force in the biotech sector, is catching the eye of investors with its robust growth potential and strategic focus on cutting-edge cell therapies...

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Evaluating a 24.85% Potential Upside Amidst Biotech Volatility

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a key player in the biotechnology sector, is at a pivotal point that presents a unique opportunity for investors. With its current market cap at..

BrightSpring Health Services (BTSG) Stock Analysis: Healthcare Innovator with 38% Upside Potential

BrightSpring Health Services, Inc. (BTSG) has captured the attention of investors with its robust growth prospects and a compelling potential upside of 38.15%. As a key player in the Healthcare..

Exact Sciences Corporation (EXAS) Stock Analysis: A 56% Potential Upside in the Healthcare Diagnostics Sector

Exact Sciences Corporation (NASDAQ: EXAS) stands as a prominent player in the healthcare sector, specifically in diagnostics and research. With a market capitalization of $7.76 billion, the company has carved..

Masimo Corporation (MASI): Investor Outlook on a 29.6% Potential Upside

Masimo Corporation (NASDAQ: MASI) stands out as a compelling investment opportunity in the healthcare sector, particularly in the medical devices industry. Headquartered in Irvine, California, Masimo specializes in innovative patient..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds